Inhibit Coatings is a New Zealand-based company specializing in durable, broad-spectrum antimicrobial and antiviral technology that chemically binds silver agents to surfaces to provide permanent, sustainable protection for various industries.
Inhibit Coatings is a biotechnology company based in Wellington, New Zealand, that develops and commercializes advanced antimicrobial and antiviral coating technology. Founded in 2016 based on research from Victoria University of Wellington, the company utilizes a proprietary chemical process to permanently bind silver-based antimicrobial agents to polymer-based materials. Unlike conventional systems that rely on the steady release of biocides, this permanent binding method prevents leaching, enhances the durability of the protection, and allows for the use of significantly lower concentrations of silver. The company's technology is broad-spectrum, effective against over 650 types of microorganisms, including various bacteria, fungi, and viruses, while remaining non-toxic and non-irritating.
This technology provides critical hygiene solutions across diverse sectors, including healthcare, food processing, public transport, and commercial facilities. By integrating their antimicrobial additives into products such as medical devices, flooring, furniture, upholstery, door handles, and curtains, Inhibit Coatings helps organizations address contamination risks and maintain cleaner environments. The company collaborates with various industry partners to develop bespoke solutions, offering a sustainable way to extend product lifespans and safeguard public spaces. Recognized with multiple international innovation awards, Inhibit Coatings continues to scale its commercial applications and research initiatives to enhance material safety and performance globally.